All In MedTech

Device Trial Radar · NCT04744935

Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma

Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

29

Actual

Start

Jan 13, 2021

Primary completion

May 20, 2025

Study completion May 20, 2025

Sponsor

Lead sponsor
Christopher ZacharyAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 9, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Optical coherence tomography guided laser treatment of basal cell carcinoma

Conditions

  • Basal Cell Carcinoma
  • Superficial Basal Cell Carcinoma
  • Nodular Basal Cell Carcinoma

Interventions

  • 1064 nm long-pulse Nd:YAG laserDevice

    BCC lesion will be treated with long-pulse 1064 laser, with surface temperature monitored by infrared camera.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete Histological Clearance of BCC LesionTime frame: 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • UCI Health Dermatology Clinic

    Irvine, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.